Navigation Links
Surprising Results on Smoking Research Hispanic Versus White Female Smokers
Date:12/3/2008

ALBUQUERQUE, N.M., Dec. 3 /PRNewswire/ -- The nation's first scientific study on the relationship between smoking and respiratory disease among Hispanic versus non-Hispanic white (NHW) women revealed that NHW women smokers were at greater risk of developing airflow obstruction and diminished lung function than Hispanic women who smoke - a surprising finding given that many diseases more adversely affect ethnic minorities. Smoking-related respiratory diseases are a major cause of death among all women.

The objective was to evaluate the risk of airflow obstruction and to assess lung function among Hispanic and NHW female smokers in a New Mexican group of participants.

Lead investigators at Lovelace Respiratory Research Institute (LRRI) - in collaboration with the University of New Mexico School of Medicine, Harvard Medical School and the University of Southern California, Los Angeles - conducted the study, which was financed by the Tobacco Settlement Commission of New Mexico. Of the 1,433 women who participated, 248 (17.3 percent) were Hispanic, 830 (57.9 percent) were current smokers, 517 (36.1 percent) smoked 40 pack-years and 422 (29.4 percent) were obese.

Dr. Yohannes Tesfaigzi of LRRI, based in Albuquerque, said, "The findings of this study were very surprising; however no Hispanic woman who smokes should believe they are immune to the many diseases that smoking causes."

While Hispanic participants were significantly more likely to be younger, overweight or obese, and had a higher prevalence of current smoking, they had a lower intensity of smoking (fewer pack-years) than NHW women. There was no significant difference in duration or age of onset of smoking, or time since smoking cessation for ex-smokers between the two groups.

Researchers discovered that Hispanic ethnicity was associated with halving of the likelihood of airflow obstruction in those female smokers, who also had better lung function compared to NHW women smokers (after adjusting for age, BMI, pack-years and duration of smoking, and current smoking status).

The findings are generally consistent with previous studies in New Mexico that showed a lower prevalence of and mortality from self-reported chronic respiratory diseases among Hispanics.

About Lovelace Respiratory Research Institute

The Lovelace Respiratory Research Institute (LRRI) is a private, biomedical research organization dedicated to improving public health through research on the prevention, treatment and cure of respiratory disease. LRRI is based in Albuquerque, NM employs 80 Ph.D.-level scientists and is a $65 million company.

    Kyla Thompson, 505-341-0699
    kyla@kylathompson.com


'/>"/>
SOURCE Lovelace Respiratory Research Institute
Copyright©2008 PR Newswire.
All rights reserved

Related medicine news :

1. Survey of Iowa Voters Reveals Surprising Results and Attitudes Toward Americas Health Care Crisis
2. Surprising New Research Indicates that Significant Numbers of Children as Young as 11 are Engaging in Sexual Activity and that Dating Violence and Abuse are Part of Their Relationships
3. Cato Study Finds Iran a Surprising Model for Kidney Markets
4. Flip Flops, Mulch and No Coat: Study Identifies Surprising Barriers to Outdoor Activity for Kids in Child-Care Centers
5. Part of the in-group? A surprising new strategy helps reduce unhealthy behaviors
6. The Largest and Most Comprehensive College Dating and Sex Survey Uncovers Surprising Behaviors of Students In and Out of the Bedroom
7. 10 Surprising Facts About Using Brain Training to Fight Dementia
8. Surprisingly, female models have negative effect on men
9. Consumer Reports Identifies Foods With Surprisingly High Levels of Sodium
10. Haemacure Reports Third Quarter 2007 Results
11. Brooke Franchise Corporation Announces Selected July Results
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:1/24/2017)... ... January 23, 2017 , ... The Pharmacy and Medically Underserved ... bipartisan original co-sponsorship of nearly one-quarter of the U.S. House of Representatives. The ... Chain Drug Stores (NACDS) strongly backs the legislation. , “NACDS thanks for their ...
(Date:1/24/2017)... ... 23, 2017 , ... The TouchPoint Solution, parent company of ... into the product’s app. The data replicates and validates Co-Founder and Neuropsychologist ... 30 seconds of using Buzzies, people experienced a 74 percent reduction in their ...
(Date:1/23/2017)... York, NY (PRWEB) , ... January 23, 2017 , ... ... announced today that John J. Nelson, a senior accountant at the Firm, will participate ... of Make-A-Wish® Hudson Valley. Over 200 runners will race up 1,576 steps, a vertical ...
(Date:1/23/2017)... FL (PRWEB) , ... January 23, 2017 , ... Wooden and plastic balance boards have ... strength and improve balance. Kumo Board is the first and only balance board ... it to be soft and rigid at the same time as well as skill-level adjustable ...
(Date:1/23/2017)... ... 2017 , ... METTLER TOLEDO has announced the availability of ... PAT Tools . , Crystallization is a common step used during ... Chemists now spend more time developing better intermediate and final crystallization steps. ...
Breaking Medicine News(10 mins):
(Date:1/24/2017)... YORK , Jan. 23, 2017 ... detect, and control light. The interaction of these ... used in a wide range of applications. These ... aerospace and defense, telecommunications, and healthcare among others. ... primarily owing to its low power consumption, reliability, ...
(Date:1/24/2017)... VALLEY COTTAGE, New York , January 23, 2017 ... Projected to Witness Sluggish Growth ... world are derived from formulating Active Pharmaceutical Ingredients (API), ... isopropanol, propanol and propylene glycol. Production of ... Asia-Pacific excluding Japan ...
(Date:1/23/2017)... 2017  Therabron Therapeutics, Inc., a clinical-stage biotechnology ... respiratory care, today announced that the European Medicines ... granted Orphan Drug Designation for Therabron,s CG367 program, ... (BOS).  "We are pleased to have ... treat patients diagnosed with BOS following lung transplantation. ...
Breaking Medicine Technology: